Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Collins

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Cancer|April 16, 2017
Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemiaHanna J Khoury, Robert H Collins, William Blum, et al.
Leukemia & Lymphoma|February 8, 2022
The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysisSuleyman Yasin Goksu, Muhammet Ozer, Busra B Goksu, et al.
Nature Cell Biology|April 28, 2015
The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia developmentXunlei Kang, Zhigang Lu, Changhao Cui, et al.
Blood|May 11, 2006
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapyH Joachim Deeg, Margaret O'Donnell, Jakub Tolar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantationJohn E Levine, Thomas Braun, Samuel L Penza, et al.
Leukemia Research|December 25, 2022
Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohortNaveen Premnath, Stephen S Chung, Olga K Weinberg, et al.
Transplant Immunology|February 26, 2023
Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experienceFieke W Hoff, Stephen S Chung, Prapti A Patel, et al.
Cell Reports|March 30, 2017
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid LeukemiaAlyssa Carey, David K Edwards, Christopher A Eide, et al.
Leukemia & Lymphoma|March 7, 2025
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohortMarisa L Kometas, Fieke W Hoff, Jonathan Hyak, et al.
Acta Medica Academica|June 16, 2023
SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center ObservationFieke W Hoff, Suleyman Y Goksu, Naveen Premnath, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Cancer|April 16, 2017
Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemiaHanna J Khoury, Robert H Collins, William Blum, et al.
Leukemia & Lymphoma|February 8, 2022
The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysisSuleyman Yasin Goksu, Muhammet Ozer, Busra B Goksu, et al.
Nature Cell Biology|April 28, 2015
The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia developmentXunlei Kang, Zhigang Lu, Changhao Cui, et al.
Blood|May 11, 2006
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapyH Joachim Deeg, Margaret O'Donnell, Jakub Tolar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantationJohn E Levine, Thomas Braun, Samuel L Penza, et al.
Leukemia Research|December 25, 2022
Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohortNaveen Premnath, Stephen S Chung, Olga K Weinberg, et al.
Transplant Immunology|February 26, 2023
Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experienceFieke W Hoff, Stephen S Chung, Prapti A Patel, et al.
Cell Reports|March 30, 2017
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid LeukemiaAlyssa Carey, David K Edwards, Christopher A Eide, et al.
Leukemia & Lymphoma|March 7, 2025
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohortMarisa L Kometas, Fieke W Hoff, Jonathan Hyak, et al.
Acta Medica Academica|June 16, 2023
SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center ObservationFieke W Hoff, Suleyman Y Goksu, Naveen Premnath, et al.
Pageof 5